Interaction of PPARG Pro12Ala with dietary fat influences plasma lipids in subjects at cardiometabolic risk

The PPARγ2 gene single nucleotide polymorphism (SNP) Pro12Ala has shown variable association with metabolic syndrome traits in healthy subjects. The RISCK Study investigated the effect of interaction between genotype and the ratio of polyunsaturated:saturated (P:S) fatty acid intake on plasma lipids...

Full description

Saved in:
Bibliographic Details
Published inJournal of lipid research Vol. 52; no. 12; pp. 2298 - 2303
Main Authors AlSaleh, Aseel, O'Dell, Sandra D., Frost, Gary S., Griffin, Bruce A., Lovegrove, Julie A., Jebb, Susan A., Sanders, Thomas A.B.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2011
The American Society for Biochemistry and Molecular Biology
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The PPARγ2 gene single nucleotide polymorphism (SNP) Pro12Ala has shown variable association with metabolic syndrome traits in healthy subjects. The RISCK Study investigated the effect of interaction between genotype and the ratio of polyunsaturated:saturated (P:S) fatty acid intake on plasma lipids in 367 white subjects (ages 30-70 years) at increased cardiometabolic risk. Interaction was determined after habitual diet at recruitment, at baseline after a 4-week high-SFA (HS) diet, and after a 24-week reference (HS), high-MUFA (HM), or low-fat (LF) diet. At recruitment, there were no significant associations between genotype and plasma lipids; however, P:S × genotype interaction influenced plasma total cholesterol (TC) (P = 0.02), LDL-cholesterol (LDL-C) (P = 0.002), and triglyceride (TG) (P = 0.02) concentrations. At P:S ratio ≤ 0.33, mean TC and LDL-C concentrations in Ala12 allele carriers were significantly higher than in noncarriers (respectively, P = 0.003; P = 0.0001). Significant trends in reduction of plasma TC (P = 0.02) and TG (P = 0.002) concentrations occurred with increasing P:S (respectively, ≤0.33 to >0.65; 0.34 to >0.65) in Ala12 allele carriers. There were no significant differences between carriers and noncarriers after the 4-week HS diet or 24-week interventions. Plasma TC and TG concentrations in PPARG Ala12 allele carriers decrease as P:S increases, but they are not dependent on a reduction in SFA intake.
Bibliography:This trial is registered at clinicaltrials.gov as ISRCTN29111298. e-mail: sandra.o'dell@kcl.ac.uk
To whom correspondence should be addressed.
ISSN:0022-2275
1539-7262
DOI:10.1194/jlr.P019281